USANA Health Sciences Inc.
USNA | NYSE
$14.76
+$0.27 (+1.86%)
Sep 22, 2026, 10:36 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Jan 2, 2026 | FY 2024 Dec 27, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 925.26M | 854.5M | 921.01M | 998.6M | 1.19B | 1.13B |
Cost of Revenue | 200.85M | 175.75M | 189.4M | 207.28M | 230.93M | 222.86M |
Gross Profit | 724.41M | 678.75M | 731.62M | 791.32M | 955.53M | 911.79M |
Operating Income | 50.86M | 66.32M | 93.07M | 107.61M | 170.19M | 176.49M |
Interest Income | 2.42M | 11.32M | 9.64M | 3.79M | 2.52M | 2.54M |
Pretax Income | 41.53M | 76.35M | 102.45M | 108.62M | 170.64M | 177.95M |
Net Income | 10.76M | 42.03M | 63.79M | 69.35M | 116.51M | 124.66M |
Selling & General & Admin | 337.37M | 600.86M | 627.1M | 672.14M | 774.23M | 724.66M |
Research & Development | n/a | 11.57M | 11.45M | 11.56M | 11.11M | 10.63M |
Other Expenses | 336.17M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 673.54M | 612.43M | 638.54M | 683.7M | 785.34M | 735.3M |
Interest Expense | 842K | 281K | 262K | 192K | 57K | 507K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 874.4M | 788.18M | 827.94M | 890.99M | 1.02B | 958.15M |
Income Tax Expense | 30.05M | 34.29M | 38.67M | 39.27M | 54.14M | 53.28M |
Shares Outstanding (Basic) | 18.57M | 19.06M | 19.25M | 19.25M | 20.15M | 21.04M |
Shares Outstanding (Diluted) | 18.57M | 19.16M | 19.35M | 19.31M | 20.34M | 21.26M |
EPS (Basic) | 0.58 | 2.20 | 3.33 | 3.60 | 5.78 | 5.89 |
EPS (Diluted) | 0.58 | 2.19 | 3.30 | 3.59 | 5.73 | 5.86 |
EBITDA | 82.07M | 98.86M | 123.11M | 130.22M | 192.89M | 200.96M |
EBIT | 42.37M | 76.63M | 102.72M | 108.81M | 170.7M | 178.46M |
Depreciation & Amortization | 39.7M | 22.23M | 20.4M | 21.41M | 22.19M | 22.51M |
Add to Watchlist
Select watchlists to add or remove USNA